Pharmacodynamic and pharmacokinetic factors in a case of neuroleptic malignant syndrome
Gespeichert in:
| Veröffentlicht in: | Journal of clinical psychopharmacology 1998-08, Vol.18 (4), p.346-347 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 347 |
|---|---|
| container_issue | 4 |
| container_start_page | 346 |
| container_title | Journal of clinical psychopharmacology |
| container_volume | 18 |
| creator | Shad, M U Preskorn, S H |
| description | |
| doi_str_mv | 10.1097/00004714-199808000-00020 |
| format | Article |
| fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1097_00004714_199808000_00020</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>9690705</sourcerecordid><originalsourceid>FETCH-LOGICAL-c310t-e5505337eafaeb1792d073ab4c0126439f547a8eb1133009d179b1a84382f5b63</originalsourceid><addsrcrecordid>eNo9kE1OwzAQhb0AlVI4ApIvEBjHdhwvUcVPpUqwALGMJo4NgcSJ7HSR2-PS0pFGo3nz3iw-QiiDWwZa3UEqoZjImNYllGnLUudwRpaQK5aBEvqCXMb4DcCEyuWCLHShQYFcko_XLww9mqGZPfatoegbOh61n9bbKWkOzTSESFtPkRqMlg6OersLQ2fHvaHHrv306CcaZ9-EobdX5NxhF-31ca7I--PD2_o52748bdb328xwBlNmpQTJubLo0NZM6bwBxbEWBlheCK6dFArLdGKcA-gmWWqGpeBl7mRd8BUpD39NGGIM1lVjaHsMc8Wg2uOp_vFUJzzVH54UvTlEx13d2-YUPLLhv7CAYro</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Pharmacodynamic and pharmacokinetic factors in a case of neuroleptic malignant syndrome</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Shad, M U ; Preskorn, S H</creator><creatorcontrib>Shad, M U ; Preskorn, S H</creatorcontrib><identifier>ISSN: 0271-0749</identifier><identifier>DOI: 10.1097/00004714-199808000-00020</identifier><identifier>PMID: 9690705</identifier><language>eng</language><publisher>United States</publisher><subject><![CDATA[Antipsychotic Agents - administration & dosage ; Antipsychotic Agents - adverse effects ; Antipsychotic Agents - pharmacokinetics ; Brain - drug effects ; Drug Interactions ; Drug Therapy, Combination ; Humans ; Lithium Carbonate - administration & dosage ; Lithium Carbonate - adverse effects ; Lithium Carbonate - pharmacokinetics ; Neuroleptic Malignant Syndrome - blood ; Neuroleptic Malignant Syndrome - diagnosis ; Paroxetine - administration & dosage ; Paroxetine - adverse effects ; Paroxetine - pharmacokinetics ; Perphenazine - administration & dosage ; Perphenazine - adverse effects ; Perphenazine - pharmacokinetics ; Serotonin Uptake Inhibitors - administration & dosage ; Serotonin Uptake Inhibitors - adverse effects ; Serotonin Uptake Inhibitors - pharmacokinetics ; Trazodone - administration & dosage ; Trazodone - adverse effects ; Trazodone - pharmacokinetics]]></subject><ispartof>Journal of clinical psychopharmacology, 1998-08, Vol.18 (4), p.346-347</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c310t-e5505337eafaeb1792d073ab4c0126439f547a8eb1133009d179b1a84382f5b63</citedby><cites>FETCH-LOGICAL-c310t-e5505337eafaeb1792d073ab4c0126439f547a8eb1133009d179b1a84382f5b63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9690705$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shad, M U</creatorcontrib><creatorcontrib>Preskorn, S H</creatorcontrib><title>Pharmacodynamic and pharmacokinetic factors in a case of neuroleptic malignant syndrome</title><title>Journal of clinical psychopharmacology</title><addtitle>J Clin Psychopharmacol</addtitle><subject>Antipsychotic Agents - administration & dosage</subject><subject>Antipsychotic Agents - adverse effects</subject><subject>Antipsychotic Agents - pharmacokinetics</subject><subject>Brain - drug effects</subject><subject>Drug Interactions</subject><subject>Drug Therapy, Combination</subject><subject>Humans</subject><subject>Lithium Carbonate - administration & dosage</subject><subject>Lithium Carbonate - adverse effects</subject><subject>Lithium Carbonate - pharmacokinetics</subject><subject>Neuroleptic Malignant Syndrome - blood</subject><subject>Neuroleptic Malignant Syndrome - diagnosis</subject><subject>Paroxetine - administration & dosage</subject><subject>Paroxetine - adverse effects</subject><subject>Paroxetine - pharmacokinetics</subject><subject>Perphenazine - administration & dosage</subject><subject>Perphenazine - adverse effects</subject><subject>Perphenazine - pharmacokinetics</subject><subject>Serotonin Uptake Inhibitors - administration & dosage</subject><subject>Serotonin Uptake Inhibitors - adverse effects</subject><subject>Serotonin Uptake Inhibitors - pharmacokinetics</subject><subject>Trazodone - administration & dosage</subject><subject>Trazodone - adverse effects</subject><subject>Trazodone - pharmacokinetics</subject><issn>0271-0749</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kE1OwzAQhb0AlVI4ApIvEBjHdhwvUcVPpUqwALGMJo4NgcSJ7HSR2-PS0pFGo3nz3iw-QiiDWwZa3UEqoZjImNYllGnLUudwRpaQK5aBEvqCXMb4DcCEyuWCLHShQYFcko_XLww9mqGZPfatoegbOh61n9bbKWkOzTSESFtPkRqMlg6OersLQ2fHvaHHrv306CcaZ9-EobdX5NxhF-31ca7I--PD2_o52748bdb328xwBlNmpQTJubLo0NZM6bwBxbEWBlheCK6dFArLdGKcA-gmWWqGpeBl7mRd8BUpD39NGGIM1lVjaHsMc8Wg2uOp_vFUJzzVH54UvTlEx13d2-YUPLLhv7CAYro</recordid><startdate>19980801</startdate><enddate>19980801</enddate><creator>Shad, M U</creator><creator>Preskorn, S H</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>19980801</creationdate><title>Pharmacodynamic and pharmacokinetic factors in a case of neuroleptic malignant syndrome</title><author>Shad, M U ; Preskorn, S H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c310t-e5505337eafaeb1792d073ab4c0126439f547a8eb1133009d179b1a84382f5b63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Antipsychotic Agents - administration & dosage</topic><topic>Antipsychotic Agents - adverse effects</topic><topic>Antipsychotic Agents - pharmacokinetics</topic><topic>Brain - drug effects</topic><topic>Drug Interactions</topic><topic>Drug Therapy, Combination</topic><topic>Humans</topic><topic>Lithium Carbonate - administration & dosage</topic><topic>Lithium Carbonate - adverse effects</topic><topic>Lithium Carbonate - pharmacokinetics</topic><topic>Neuroleptic Malignant Syndrome - blood</topic><topic>Neuroleptic Malignant Syndrome - diagnosis</topic><topic>Paroxetine - administration & dosage</topic><topic>Paroxetine - adverse effects</topic><topic>Paroxetine - pharmacokinetics</topic><topic>Perphenazine - administration & dosage</topic><topic>Perphenazine - adverse effects</topic><topic>Perphenazine - pharmacokinetics</topic><topic>Serotonin Uptake Inhibitors - administration & dosage</topic><topic>Serotonin Uptake Inhibitors - adverse effects</topic><topic>Serotonin Uptake Inhibitors - pharmacokinetics</topic><topic>Trazodone - administration & dosage</topic><topic>Trazodone - adverse effects</topic><topic>Trazodone - pharmacokinetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shad, M U</creatorcontrib><creatorcontrib>Preskorn, S H</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Journal of clinical psychopharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shad, M U</au><au>Preskorn, S H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pharmacodynamic and pharmacokinetic factors in a case of neuroleptic malignant syndrome</atitle><jtitle>Journal of clinical psychopharmacology</jtitle><addtitle>J Clin Psychopharmacol</addtitle><date>1998-08-01</date><risdate>1998</risdate><volume>18</volume><issue>4</issue><spage>346</spage><epage>347</epage><pages>346-347</pages><issn>0271-0749</issn><cop>United States</cop><pmid>9690705</pmid><doi>10.1097/00004714-199808000-00020</doi><tpages>2</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0271-0749 |
| ispartof | Journal of clinical psychopharmacology, 1998-08, Vol.18 (4), p.346-347 |
| issn | 0271-0749 |
| language | eng |
| recordid | cdi_crossref_primary_10_1097_00004714_199808000_00020 |
| source | MEDLINE; Journals@Ovid Complete |
| subjects | Antipsychotic Agents - administration & dosage Antipsychotic Agents - adverse effects Antipsychotic Agents - pharmacokinetics Brain - drug effects Drug Interactions Drug Therapy, Combination Humans Lithium Carbonate - administration & dosage Lithium Carbonate - adverse effects Lithium Carbonate - pharmacokinetics Neuroleptic Malignant Syndrome - blood Neuroleptic Malignant Syndrome - diagnosis Paroxetine - administration & dosage Paroxetine - adverse effects Paroxetine - pharmacokinetics Perphenazine - administration & dosage Perphenazine - adverse effects Perphenazine - pharmacokinetics Serotonin Uptake Inhibitors - administration & dosage Serotonin Uptake Inhibitors - adverse effects Serotonin Uptake Inhibitors - pharmacokinetics Trazodone - administration & dosage Trazodone - adverse effects Trazodone - pharmacokinetics |
| title | Pharmacodynamic and pharmacokinetic factors in a case of neuroleptic malignant syndrome |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T03%3A10%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pharmacodynamic%20and%20pharmacokinetic%20factors%20in%20a%20case%20of%20neuroleptic%20malignant%20syndrome&rft.jtitle=Journal%20of%20clinical%20psychopharmacology&rft.au=Shad,%20M%20U&rft.date=1998-08-01&rft.volume=18&rft.issue=4&rft.spage=346&rft.epage=347&rft.pages=346-347&rft.issn=0271-0749&rft_id=info:doi/10.1097/00004714-199808000-00020&rft_dat=%3Cpubmed_cross%3E9690705%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/9690705&rfr_iscdi=true |